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Suml'rl.sry 
The mature T cell receptor (TCK) repertoire is established on the basis of discriminative events 
involving binding of the TCR c~ and 3  chains and CD4 or CD8 on immature thymocytes to 
major histocompatibility  complex (MHC)Aelf-peptide  complexes expressed in the thymus.  To 
ask whether the strength of the interaction  between a CDS/TCR complex and a MHC/self- 
peptide ligand plays a pivotal role in deciding the fate of a maturing thymocyte, we generated 
lines of transgenic mice that express distinct  and elevated levels of CD8oe, approximately 2, 3, 
and 6-10 times. These lines were then crossed to a transgenic line expressing the class I-restricted 
TCR, 2C. We found that thymocytes expressing the 2C TCR in combination with the highest 
levels of CD8 were deleted on the H-2 K  b background that is normally positively selecting for 
the 2C TCR. In contrast,  thymocytes coexpressing the 2C TCR and moderately elevated levels 
of CD8 were selected for maturation. These results demonstrate directly that CD8 levels can 
affect the developmental fate of a maturing thymocyte and argue in support of an affinity model 
for thymocyte selection. 
M 
ature T lymphocytes  recognize foreign Ag in the form 
of processed peptides bound to MHC molecules. The 
recognition of the peptide-MHC ligand is mediated by the 
o~/3 TCK complex and CD4 or CD8. Modeling studies in- 
dicate that the variable regions of the TCR simultaneously 
contact the antigenic peptide and the polymorphic ce helices 
that flank the peptide binding groove of MHC molecules 
(1-3).  CD4 and CDS, on the other hand, contact mono- 
morphic determinants on MHC class II and class I molecules, 
respectively (4-8), and are believed to be intimately involved 
with the TCR in corecognition of Ag-MHC complexes (9, 
10). The cytoplasmic domains  of both CD4 and CD8 are 
physically associated with the lymphocyte-specific tyrosine 
kinase, p561r  (11-14), and thus, the coreceptor functions of 
CD4 and CD8 may include collaboration with the TCR com- 
plex to transduce transmembrane signals upon recognition 
of antigen (15, 16). Functional studies on CTL have demon- 
strated a direct correlation between the CD8 dependency of 
CTL clones and the density of the peptide Ag-class I MHC 
determinants on a target cell (17-19). Since the TCR and 
CD8 on CTL have been shown to interact with the same 
antigenic class I molecule (9, 10), these findings suggest that 
the CD8 coreceptor may actually contribute to the affinity 
of a TCR for its Ag-class  I MHC ligand. 
Mature CD4 §  CD8-  and CD4- CD8 + T  cells differen- 
tiate in the thymus from fetal liver or adult bone marrow-de- 
rived stem cells that express neither the or/3 TCK nor CD4 
and CD8 (reviewed in reference 20). The major intermediate 
in the T cell differentiation pathway is the double-positive 
thymocyte, which expresses both CD4 and CD8 and low 
levels of the ol/3 TCR.. Two selective forces are known to 
operate during thymocyte maturation to choose the c~/~ TCR 
repertoire expressed  on mature T cells. Positive  selection  rescues 
from cell death those thymocytes  that will be able, as mature 
T cells, to engage self-MHC molecules that have bound for- 
eign antigen;  negative selection either eliminates or inacti- 
vates thymocytes  bearing autoreactive ol/3 TCKs (reviewed 
in references  20-22). Consequently, only a subset of the TCK 
specificities expressed on immature thymocytes  are found on 
mature peripheral T  lymphocytes. 
Studies on T cell selection using bone marrow and thymus 
chimeras (23) and class II transgenic mice (24, 25) suggest 
that positive and negative selection may be separable events 
mediated largely by distinct subsets of thymic stromal cells, 
radiation-resistant  thymic epithelial cells in the case of posi- 
tive selection, and bone marrow-derived APC and medul- 
lary epithelial cells in the case of negative selection (26). How- 
ever, both positive and negative selection appear to depend 
on the formation of a complex between the oe/~ TCK and 
MHC  molecules  bound to  self-peptides (27-30).  Conse- 
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how the positively selected thymocytes escape clonal dele- 
tion  or anergy (20,  21). 
The  affinity  model  has  been  proposed  to  resolve  this 
paradox.  This model suggests that  the fate of a maturing 
thymocyte is determined by the strength of the interaction 
between a MHC/self-peptide ligand and a multimeric com- 
plex containing  the ot/B TCR and CD4 or CD8.  Thymo- 
cytes bearing low affinity receptors are selected for matura- 
tion, whereas thymocytes bearing intermediate or high affinity 
receptors  are  subject  to  negative  selection,  and  are  either 
clonally inactivated or deleted. One prediction of the affinity 
model is that  increasing  the affinity of an or//5 TCR for a 
selecting MHCAdf-peptide ligand should convert a positively 
selecting interaction into one that is negatively selecting. To 
test this prediction,  we attempted to change the avidity of 
thymocyte/stromal cell interactions by increasing the surface 
levels of CD8 on maturing thymocytes. Transgenic lines ex- 
pressing elevated levels of murine  CDSol on all subsets of 
thymocytes  and  mature  T  cells  were  generated  and  then 
crossed, on what is a normally positively selecting background, 
to a transgenic line expressing a class I-restricted TCR. We 
find that  thymocytes coexpressing the TCR transgene  and 
moderately elevated levels of CD8 are selected for matura- 
tion, whereas thymocytes expressing the TCK transgene and 
markedly enhanced levels of CD8 are deleted; thus, our results 
support  the affinity model for thymocyte selection. 
Materials  and Methods 
Construction of the pNeZCD8cx.1 Plasmid.  The CD8~x.1 allele 
of CD8c~ was isolated from a CBA/J genomic library prepared from 
MboI partially digested liver DNA in the )~ vector EMBL3. To 
distinguish between transcripts of the CD8c~.I transgene and the 
endogenous CD8c~.2 gene, a D0-bp fragment from the 3' untrans- 
lated region of the sea urchin actin gene CyIIIa (31) was inserted 
into a Sad site in the 3' untranslated region of CD8c,.1. To prepare 
the pNeZ/ZD8o~.l phsmid, sequences 5' of the PvulI site lying ,~125 
bp upstream  from  the initiating  ATG (32) were  deleted.  This 
promoterless CD8~.l/actin gene was cloned into a CD3-/~ cassette. 
The pNeZ cassette was prepared in pNNO3 (a gift from R. Tiz- 
zard, Biogen, Cambridge,  MA) by first inserting  a 0.6 kb NarI- 
EcoRI restriction fragment carrying the murine CD3-~ enhancer 
(33) into a BamHI site using BamHI linkers. A second fragment 
containing the BclI-Bcll promoter region of CD3-/~ (33) was cloned 
into the SmaI and HindIII sites of this plasmid. 
Generation of CD8e~.l Transgenic  Mice  The plasmid pNe7_.CD8c~.l 
was digested with NotI to excise the CD3-#/CD8cx.1  sequences 
from the plasmid vector. The DNA was isolated from an agarose 
gel by electrophoresis onto a dialysis membrane, phenol extracted, 
and ethanol precipitated. The purified DNA was injected at a con- 
centration of 1-5 ng/gl in 5 mM Tris-HC1, pH 7.4, 5 mM NaC1, 
0.1 mM EDTA into fertilized eggs of the C57BL/6J inbred strain 
(The Jackson Laboratory, Bar Harbor, ME). To generate line 2761, 
the pNeZD8c~.l fragment was coinjected with a 5.5-kb BamHI- 
XbaI restriction  fragment  containing  the human  CD2 enhancer 
(a gift from D. Kioussis, National Institute for Medical Research, 
London;  34). DNA purified from cut tail tips was digested and 
analyzed for integration  of the transgene by hybridization  with 
a CD8cr cDNA probe (a gift ofD. Littman, University of California, 
San Francisco). 
Purification and Staining of Lymphocytes.  Tissues were homo- 
genized by crushing between two frosted glass slides in PBS with 
1% BSA, 0.1% sodium azide followed by filtration through Nitex 
mesh (no. 3-40/26;  Tetko Inc., Ehnsford,  NY). Red blood cells 
were lysed in 0.15 M ammonium chloride, 10 mM potassium bi- 
carbonate, 0.1 mM EDTA for 5 min on ice. Lymphocytes were 
washed and ~106 cells per sample were stained with saturating 
concentrations  of antibody. Cells were washed again and stained 
with secondary reagents as indicated in the figure legends. Splenic 
T cells were prepared by hbeling splenocytes with anti-lap (mouse 
IgG2A; Accurate Chemical & Scientific Corp., Westbury, NY) fol- 
lowed by depletion with goat anti-mouse IgG-coated magnetic 
beads (Advanced Magnetics, Cambridge, MA). Stained cells were 
fixed in PBS with 1% formaldehyde, 0.1% sodium azide and ana- 
lyzed on a FACScan  |  flow cytometer using FACScan  |  Research 
Software (Becton Dickinson  & Co.,  Mountain  View, CA).  The 
three-color analyses using anti-CD8c~.l,  anti-CD8c~.2, and anti- 
1B2 were accomplished by staining first with anti-CDSc~.l (clone 
01MLeuKO3) and anti-CD8c~.2 (clone 2.43), followed by staining 
with FITC-labeled goat anti-mouse Ig (Becton Dickinson & Co.) 
and PE-labeled goat anti-rat Ig (Tago Inc., Burlingame, CA). The 
washed cells were treated with purified mouse Ig (Sigma Chemical 
Co.,  St. Louis, MO), then with biotinylated  anti-lB2,  followed 
by staining with streptavidin-red 613. Dead cells were eliminated 
from the analysis on the basis of forward and sideways  light scatter. 
5,000 cells were analyzed for each plot for two-color analysis, and 
15,000 cells for three-color  analysis. 
Antibodies.  The following mAbs were used for staining: anti- 
CDSc~, clone 53-6.7; anti-CD4,  clone GK1.5; anti-Thy-l.2, clone 
30-H12 were from Becton Dickinson & Co. Anti-CDSot.1, clone 
01MLeuKO3  and  anti-laP,  clone  4-16.17 were  from  Accurate 
Chemical & Scientific Corp. Anti-CD8a.1,  clone 116-13.1 and anti- 
CD8c~.2, clone 19/178 were gifts from Drs. S. Kimura and U. Ham- 
merling (Sloan-Kettering Institute). Anti-CD8c~.2, clone 2.43 was 
a gift from Dr. J. Nikolic-Zugic (Sloan-Kettering Institute).  Anti- 
TCR-c~/~, clone 57-597 and anti-Lyt-3 (CDSB) were from Phar- 
mingen (San Diego, CA). The anti-2C TCR antibody is 1.82 (35). 
Anti CD3e, clone 145-2Cll was from Boehringer Mannheim Bi- 
ochemicals, Indianapolis, IN. Several secondary antibodies and re- 
agents  were  used.  Streptavidin-PE,  avidin-FITC,  and  goat 
anti-mouse Ig-FITC were obtained from Becton Dickinson & Co; 
goat anti-rat  Ig F(ab')-PE and goat anti-mouse Ig F(ab')-FITC and 
-PE were from Tago Inc.; goat anti-rat Ig-FITC was from Southern 
Biotechnology Associates (Birmingham, AL); streptavidin-red 613 
was from Bethesda Research Laboratories (Gaithersburg, MD); and 
purified mouse Ig was from Sigma Chemical Co. 
Results 
Generation of CD8c~.1 Transgenic Mice.  To direct expres- 
sion of a CD8c~ transgene to all subclasses of thymocytes and 
peripheral  T  cells,  the routine  CDSc~.I  gene was inserted 
downstream of the murine CD3-6 promoter and enhancer 
in the construct pNeZCD8ol.1 (Fig.  1). The murine CD34t 
enhancer is located in a DNase I hypersensitive area at the 
Y end of the CD3-/~ gene and functions in transient transfec- 
tion assays as a position- and orientation-independent regula- 
tory element that targets the transcription  of heterologous 
genes  specifically  to  T  cells (33).  Therefore,  we predicted 
that the CD3-~ enhancer should act as a T ceU-specific regu- 
latory  dement  in  transgenic  mice  and  target  transgene 
expression to both the CD4 and CD8 T  cell subsets. The 
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Figure 1.  Diagram of the pNe- 
ZCD8a.1 expression  plasmid. The 
components of this phsmid include 
the murine CD3-6 sequences  neces- 
sary for T cell-specific  expression, 
as indicated  by dark stippling: a 0.6- 
kb Narl-EcoRI  restriction fragment 
containing the CD3-/}  enhancer se- 
quences and a 0.5-kb BclI-BdI re- 
striction fragment comprising the 
5' upstream regulatory sequences 
(33, 64). Exons 1-5 of the murine CD8a.1 gene, as reported by Liaw et al. (32), are indicated by black boxes; the 5' and 3' nontranslated regions, 
by white boxes. The lightly stippled box within the Y nontranslated region denotes a 130-bp fragment of the sea urchin actin gene, pCylIIa (31), 
which was inserted to provide  a distinction between  endogenous and transgene transcripts. A Notl restriction digest was performed to sever the plasmid 
vector pNNO3 from the sequences microinjected into fertilized mouse eggs. 
pNeZCD8c~ transgene was microinjected into fertilized eggs 
derived from the C57BL/6J (B6) strain. This strain expresses 
the CD8ol.2 allele; thus, transgene expression can be distin- 
guished from endogenous gene expression by surface staining 
with antibodies that  distinguish between the o~.1 and o~.2 
alleles of CD8.  Five transgenic lines were generated.  These 
lines were initially screened for transgene expression by as- 
saying for the presence of mature peripheral  CD4+CD8 + 
double-positive T cells. Splenic T cells were analyzed by two- 
color FACS  |  analyses using antibodies specific for CD4 and 
both alleles  of CD8.  We found that  two of the five lines, 
lines 151 and 140, contained significant numbers of double- 
positive peripheral  T cells and expressed elevated levels of CD8 
on both splenocytes and thymocytes (Fig.  2). An additional 
four lines were generated by coinjecting the pNeZCD8cr 
transgene and a fragment containing the T  cell-specific en- 
hancer from the human CD2 gene (34). One of these lines, 
2761, also expressed elevated levels of CD8ol and was chosen, 
along with lines 151 and 140,  for further characterization. 
The CD8oL1 Transgene Is Expressed at Distinct and Elevated 
Levels on Thymocytes and Peripheral T Cells of Lines 151, 2761, 
and 140.  Splenocytes and thymocytes from lines 151, 2761, 
and 140 were stained with antibodies to CD4 and CD8, and 
an example of the resulting two-color FACS  ~ profiles is shown 
in Fig. 2. In lines 151 and 2761,  100% of the CD4 + spleno- 
cytes coexpress CDf. Relative to endogenous levels of CD8 
on control B6 splenocytes, the CD4 + CD8 + splenocytes in 
Fig.  2 express 2.4- and 3.8-fold elevated levels of CD8 in, 
respectively, lines 151 and 2761.  Averaging relative values of 
CD8 fluorescence from several independent transgenic mice, 
the CD8 levels on CD4 + CD8 + splenocytes range from 1.5 
to 3 times in line 151 and two to four times in line 2761. 
In  line  140,  the  pNeZCD8ot.1  transgene  is  expressed  on 
'~83%  of CD4 +  splenic  cells,  generating  a CD4+CD8 + 
subset that  represents  20%  of the T  cell-enriched  spleno- 
cytes. The level of transgene expression on the double-positive 
cells is approximately sixfold higher than endogenous gene 
expression,  as indicated by the difference in mean CD8 fluores- 
cence between the CD8 + single-positive cells in the control 
B6 mouse and the CD4 + CD8 + double-positive cells in the 
line 140 mouse, 46 and 280,  respectively. The data in Fig. 
2, as well as additional two-color FACS  |  analyses of spleno- 
cytes from line  140 mice (see Fig.  6), reveal  that  there are 
two distinct populations of the CD4-CD8 + single-positive 
T cells in line 140 mice, CD8  "~  and CD8~; the latter con- 
tain  •60%  of the  CD4-CD8 +  subset  and  stain  with  a 
mean CD8 fluorescence that is approximately sevenfold more 
intense than that on CD8  "~  cells (see Fig. 6). In contrast, 
only a single CD4-CD8 + population  is observed in lines 
151 and 2761, staining at levels approximately twofold higher 
than  those on controls. 
Hg. 2 also shows that lines 151, 2761, and 140 express CD8 
on nearly 100% of all thymocytes. Line 151 thymocytes ex- 
press CD8 at 2.2-fold increased levels, giving a mean CD8 
fluorescence of 177 compared with a mean CD8 fluorescence 
of 81  on  the  CD4+CD8 +  thymocytes in  the  control  B6 
mouse. Line 2761 thymocytes express CD8 at 2.8-fold elevated 
levels (a mean CD8 fluorescence of 226 vs. 81) and line 140 
CD4+CD8 + thymocytes at 7.8-fold elevated levels (a mean 
CD8 fluorescence of 630 vs. 81). These elevated levels of CD8 
have been consistently observed in numerous animals of var- 
ious ages and thus are a stable phenotype of these transgenic 
lines. 
To establish whether the elevated levels of CD8 expression 
in the CD8 transgenic lines are due entirely to the expression 
of the pNeZCD8o~.I transgene,  splenic T  cells from trans- 
genic and nontransgenic B6 littermates were costained with 
anti-CD4 and either anti-CD8o~.l or anti-CD8c~.2  antibodies. 
Fig. 3 A  presents the staining profile of the purified splenic 
T  cells  from  a  line  140  mouse.  The  CD4+CD8 +  subset 
reacts  with  the  anti-CD8,v.1  antibody but  not  the  anti- 
CD8oL2 antibody, demonstrating that virtually all of the CD8 
expression on the double-positive peripheral T cells represents 
transgene  expression.  Likewise, since the level of CD8c~.2 
staining on the CD8 single-positive subset does not vary be- 
tween control B6 and line 140 mice (Fig. 3 A), the enhanced 
levels of CD8 staining on CD4- CD8 + subpopulation must 
result  exclusively from  transgene  expression.  Comparable 
results were also obtained from FACS  |  analyses  examining 
CDfot.1 and CDfot.2 expression on splenocytes from line 
151 and 2761 mice. 
Fig.  3 B  shows the two-color FACS  |  profile of thymo- 
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Figure 2.  CD4 and CD8 surface  phenotype of splenic  T cells and thymo- 
cytes from normal and CD8ol.1 transgenic mice. Flow cytometric analysis 
was performed by double-color  staining with PE-conjugated  anti-CD4 
and FITC-conjugated anti-CD8. The percentages of total cells  in each quad- 
rant are indicated on each plot. Fluorescence intensities are indicated on 
a logarithmic scale. Greater than 10 mice from each transgenic line have 
been analyzed at ages between 3 wk and 8 mo. The data shown for non- 
transgenic C57BL/6J (B6) or transgenic lines 151, 2761, and 140 represent 
cells from  a single mouse killed at 8 wk of age. 
cytes from line 140 transgenic and nontransgenic littermates 
after staining with anti-CD4 and either anti-CD8o~.l or anti- 
CD8oe.2 antibodies. As found with the splenic T cells, thymo- 
cytes from both line 140 and B6 control mice express com- 
parable levels of the endogenous CD8c~.2 gene, arguing that 
the approximately eightfold elevated levels of CD8 in the 
thymus result entirely from transgene expression.  Similar 
FACS  |  analyses, using CD8o~.I- and CDfc~.2-specific  anti- 
bodies to stain thymocytes from lines  151 and 2761, show 
that  levels of the endogenous CD8cr  gene product are 
unaffected and thus that the elevated CD8 levels in these trans- 
genics also result from expression of CDfc~.I transgene. Con- 
sequently,  in none of the CD8 lines has expression  of the 
pNeZCD8oL.1 transgene perturbed expression of the endog- 
enous CD8c~ gene product on either immature or mature 
T  cells. 
Our data indicate that, on average, 80% and 60%, respec- 
tively, of the peripheral CD4 + and CD8 § T cell subsets ex- 
press the pNeZCDfc~.I transgene in line 140 mice. In addi- 
tion, based on staining with the CDfol.1 antibody, only 80% 
of thymocytes in line 140 mice express the CD8 transgene. 
The incomplete expression  of the pNeZCD8o~.I  transgene 
in line 140 mice most likely represents a chromosomal posi- 
tion effect, as lines 151 and 2761, as well as additional lines 
of mice carrying pNeZCDfc~.I or other CD3-#-driven trans- 
genes, express these transgenes on 100% of peripheral T cells 
and thymocytes (N.A.  Lee, D. Grass, and E. Lacy, unpub- 
lished results).  Such chromosomal position effects, leading 
to line-spedfic patterns of transgene expression, are commonly 
observed in transgenic mice (36-39). 
pNeZCD8oL1  Transgene-expressing Cells Show Normal Levels 
of Other  T  Cell  Surface Markers.  To determine whether 
elevated levels of CD8 expression affect normal T cell devel- 
opment, we have examined the expression of CD8B, CD3, 
and the o~/j8 TCR on thymocytes and splenic T cells in the 
CD8 transgenic mice.  CD8 is expressed  on the surface of 
most thymocytes and mature T cells as a disulfide-linked cr 
heterodimer (40-42). In the absence of CD8B, however, CD8ol 
can be expressed as a homodimer (43, 44).  CD8B, on the 
other hand, requires CD8c~ for ceU surface expression (44-46). 
We have investigated whether the high levels of CD8o~ ex- 
pression in the line 140 mice can increase the surface levels 
of CDfB by performing three-color FACS  |  analyses using 
antibodies to CD8~/, CD4, and CD8c~ (Fig. 4). Our results 
show that surface levels of CD8B are not enhanced in line 
140 mice. Consequently, we conclude that a pool of excess 
CD8B chains does not normally exist in T cells and that the 
surface level of the CD8c~/B heterodimer is not determined 
solely by limiting quantities of CD8c~ chain. In addition, 
no CD8~8 expression is detected on the CD4+CD8 + periph- 
eral T cells expressing the CD8c~.I transgene. Together, these 
findings argue that the elevated levels of CD8 are expressed 
in the form of ot/c~ homodimers on thymocytes and periph- 
eral T  cells of the CD8 transgenic mice. 
When stained with an anti-CD3 antibody, thymocytes from 
both line 140 mice and nontransgenic littermates yielded com- 
parable single-color FACS  |  profiles (data not shown). The 
CD8o~ and TCRodB two-color staining profile (Fig. 5, bottom) 
shows that "~80% of the CD8 cells in lines 151, 2761, and 
140 express the TCR-od~. The non-TCR-c~/~/staining CD8 
ceils presumably result from expression  of the CD3-6 en- 
hancer-driven CD8 transgene in B lymphocytes. Although 
the CD3-~ enhancer functions preferentially in T lympho- 
cytes, characterization of other transgenes driven by the CD3-~ 
enhancer indicates  that it has some specificity for B cells as 
well (D. Grass and E. Lacy, unpublished data). In Fig. 5, top 
and middle, the CD8 fluorescence of total lymphocytes and 
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Figure 3.  Surface phenotype of splenic T cells and thymocytes from normal and line 140 mice. Flow cytometric analysis was performed as described 
in Fig. 2, except that cells were stained with PE-conjugated anti-CD4 and either anti-CD8oe.1 (clone 116-13.1) or anti-CD8a.2 (done 19/178) followed 
by staining with FITC-conjugated goat anti-mouse Ig. This CD8~.1 antibody stains lymphocytes from line 140 with a mean channel value of CD8 
fluorescence that is five- to sixfold greater than that of lymphocytes from CBA/J mice, which carry the endogenous CDSa.1 allele (data not shown). 
the TCR-c~/3 + subset is plotted as a histogram. These data 
demonstrate directly that the vast majority of TCR-c~/3 + 
cells do express the elevated levels of CD8 characteristic of 
lines 151, 2761, and 140. All subsets in the transgenic mice 
(CD4+CD8 - , CD4+CD8 hi, CD4-CD8 "~  [in line 140], 
and CD4-CD8 hi) express levels of the TCR-oe//J complex 
that are identical to those detected on splenic T  ceils from 
nontransgenic mice. This is shown for the CD8 + cells in 
Fig.  5,  bottom,  in which the mean TCR-od3  fluorescence 
of the CD8+TCR-oL/3 + splenic T  cells is  104 for the B6 
mouse, and 104, 107, and 96, respectively, for the line 151, 
2761,  and 140 mice. Consequently, on the basis  of TCR- 
c~/3 expression, we have found no evidence that high levels 
of CD8 grossly perturb T  cell maturation. 
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Figure 4.  Expression  of the en- 
dogenous CD83 gene is unaffected 
in transgenic line 140 mice. Three- 
color FAC-~ analysis  was performed 
on splenocytes from nontransgenic 
C57BL/6J (B6) and transgenic line 
140 mice. Splenocytes were stained 
with  PE-conjugated  anti-CD4, 
HTC-conjugated anti-CD8oL, and 
biotinylated anti-CD83,  followed 
by staining with  streptavidin red 
613.  Five mice of each  genotype 
were analyzed; the data shown rep- 
resent those of one individual The 
mean CDSB fluorescence on splenic 
T  cells is 85 in control B6 mouse 
and 77 in the line 140 mouse. 
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Figure 5.  Cell surface expression 
of the TCR-od[3 on splenic T cells 
in line 151, 2761, and 140 trans- 
genics. Splenic T  cells from non- 
transgenic  C57BL/6J (86) and trans- 
genic line 151, 2761, and 140 mice 
were labeled with biotinyhted  anti- 
TCR-~x/~ anti-CD8 (FITC),  and 
anfi-CD4 (PE), followed  by staining 
with streptavidin  red 613. Four mice 
of each genotype were analyzed; the 
data shown represent those of one 
individual.  (~bp and m/dd/e) Rela- 
tive cell number  versus CD8 fluores- 
cence for, respectively, total splen- 
ic  lymphocytes  and  TCR-~x/3 + 
splenic  T  cells. The  histogram 
markers are numbered 1-4, from 
bottom to top. (Marker 2) The left 
boundary of which is set at 10, dis- 
tinguishes the CD8- cells from the 
CD8 §  cells; (marker  4)  the  left 
boundary of which is set at 100, dis- 
tinguishes the CD8  "~  cells form 
the CD8  hi ceils. (~p) The mean 
CD8 fluorescences of all lympho- 
cytes staining for CD8 (marker 2) 
are 26 (136), 55 (151), 61 (2761), and 
148 (140); the mean CD8 fluores- 
cence for  the CD8  hi cells in line 
140 (marker 4) is 228. (Middle) The 
mean CD8 fluorescences  (marker 2) 
for  the  TCR-odB +  lymphocytes 
are 26 (]36), 59 (151), 69 (2761), and 
175 (140); the mean CD8 fluorescence of the CD8  hi TCR-ot/~ + cells in line 140 is 225. (Bottom) CD8~ vs. TCR-od3 FACS  |  profile of T cell-en- 
riched splenocytes in nontransgenic  B6 mice:  and line 151, 2761, and 140 mice. The numbers in each corner of the contour plots represent the percentage 
of cells staining in each quadrant.  The mean TCR-ot/~ fluorescences of the CD8 + TCIk-ot/f3 + cells are 104 (B6), 104 (151), 107 (2761), 96 (140), 
and 103 (CD8 hi, 140). 
CD8  ~ Cells Are Deleted in 2C TCR  7~ansgenic Mice.  Line 
151, 2761, and 140 mice were crossed to transgenic mice ex- 
pressing the 2C class I-restricted TCR to determine whether 
elevated levels of CD8 expression could alter the developmental 
fate of a maturing  thymocyte bearing  a TCR  of known 
specificity on its cell surface. This TCR transgenic line, which 
like the CD8 transgenics is on an H-2  b background, carries 
the rearranged ot and 3  chain genes of the TClk expressed 
in the La-speeific cytotoxic T  cell clone, 2C (47-48).  The 
2C clone was originally derived from a BALB/b (H-2  b) anti- 
BALB/c (H-2  a) MLC (35). Previous studies of Sha et al. (27) 
have demonstrated that positive selection of the 2C TCR is 
mediated by the K b class  I  molecule.  On  an  H-2  b back- 
ground, 55-75%  of peripheral T cells express the 2C TCR 
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Figure  6.  Splenic  T  cells ex- 
pressing high levels  of CD8 are ab- 
sent in the line 140+2C + double 
transgenics. Two-color FACS  Q anal- 
3,sis was performed on splenic  T cells 
from line 140 or 2C single trans- 
genics and 140 +  2C + double trans- 
genic  mice  stained  with  FITC- 
conjugated  anti-CD8  and  PE- 
conjugated  anti-CD4. Plots  were 
analyzed  with two sets of  quadrants 
and the numbers shown represent 
the percentages of total cells in each 
of the depicted six divisions. Rep- 
resentative data from one individual 
(of 10 analyzed at 8-12 wk of age) 
of each genotype are shown. 
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Figure  7.  Three-color flow cytometry analysis of line 151*2C  +, 
2761 +  2C + and 140 +  2C + double transgenics. Splenocytes  were stained 
with FITC-conjugated  anti-CD8, PE-c0njugated  anti-CD4, and biotinylated 
anti-2C (1B2), followed  by staining  with streptavidin  red 613. (Left)  CD8 
fluorescence  plotted versus relative  cell number for all splenocytes; (right) 
CD8 fluorescence  plotted  versus  relative  cell  number  for cells  staining  positive 
for the 2C TCK (1132+). Markers are numbered 1-4, from  bottom to top. 
(Marker 2) The left boundary  is set at 10, and distinguishes  the CDS- 
cells from the CD8 + cells; (marker 4) the left boundary  is set at 66, and 
distinguishes the CD8  n~  from the CD8  hi cells. The mean CD8 fluores- 
cences of the CD8 + cells are 25 (B6), 58 (151), 109 (2761), 171 (140), 
285 (CD8  hi, 140), 21 (2C), 77 (151, 2C), 102 (2761, 2C), 25 (140, 2C), 
and 123 (CDShi; 140, 2C). 
transgene and >90% of these are CD4-CD8 + . The initial 
2C  x  CD8 transgenic crosses used the line 140 mice, since 
these animals expressed the highest levels of the CDSc~.I trans- 
gene. Three classes of transgenic progeny were generated in 
the  2C  x  line  140  cross  (140*2C -,  140*2C +,  and 
140-2C +) and 5-10 animals in each class were examined by 
two- and three-color FACS  |  analyses to monitor the fate of 
the 2C + thymocytes and peripheral T  cells. Samples of the 
data obtained are presented below. 
Fig.  6 presents the CD4/CD8 profile of splenic  T  cells 
from the transgenic progeny produced in the 2C  x  line 140 
cross. The percentage of CD4-CD8 + splenic T cells in the 
140*2C +  mice  (60%)  is  comparable  with  that  in  the 
140- 2C + single transgenic (55 %). However, whereas 59% 
of the 140+2C -  splenic T cells stain brightly with anti-CD8 
antibodies (including 17% that stain as CD4-CDS+), only 
8%  of splenic  T  cells  stain at  this level in the  140+2C + 
double transgenic progeny.  Specifically, the percentage of 
CD4-CD8 hi cells is decreased,  from 17% in the 140+2C - 
transgenic to 7% in the 140*2C + double transgenic.  When 
comparing the relative levels of CD8 fluorescence among the 
three classes of transgenic progeny, we find that the mean 
CD8 fluorescence of the CD4-CD8 + population is similar 
in  the  140+2C +  double  and  the  140-2C +  single  trans- 
genics:  66 and 50, respectively.  In contrast, the mean CD8 
fluorescence of the CD4- CD8  h~ cells in the 140 +  2C-  mice 
is 364,  approximately sevenfold higher than the CD8 levels 
found on splenic T cells in the 140-2C + single transgenics 
(Fig.  6).  A  small number of CD4-CD8 hi cells is observed 
in the double transgenic and these cells stain with a mean 
CD8 fluorescence of 241, a value that is reduced relative to 
the mean CD8 fluorescence (364) observed on CD4-CD8 hi 
cells in the 140 +  2C-  transgenic mouse. The absence of pe- 
ripheral CD8  hi cells is also reflected by the decrease in the 
number of cells staining brightly for the CD8c~.I transgene. 
In  line  140, •60-80%  of peripheral  CD8 +  cells  stain 
brightly for  CD8c~.I,  whereas,  in  the  140+2C +  double 
transgenic, <12% of CD8 + cells stain brightly for CDSol.1 
(data not shown; these numbers represent averages from four 
mice). 
The data in Fig.  6 clearly show that there is a reduction 
in the percentage of CD8  hi cells in  the  140+2C + double 
transgenic relative  to the 140+2C -  single transgenic. Fur- 
thermore,  the level of CD8  staining on the CD4-CD8 hi 
cells appears to be somewhat lower in the double transgenic 
compared with the 140+2C -  single transgenic. These data 
do not establish, however,  whether the 2C TCR + cells in 
the 140+2C + double transgenic express normal, moderate, 
or high levels of CDS. Therefore, we performed three-color 
FACS  |  analyses on splenocytes  using the 1B2 antibody, a 
clonotypic antibody specific for the 2C TCR (35), and anti- 
CD4 and anti-CD8 antibodies. To determine whether the 
loss of CD8  ~ splenocytes in a CD8  x  2C double transgenic 
is dependent on the actual level of CD8 transgene expres- 
sion, single and double transgenic progeny from the 2C  x 
151 and 2C  x  2761 crosses were included in this analysis. 
The data are shown in Fig. 7, which plots CD8 fluorescence 
versus relative cell number (left) for total splenic lymphocytes 
from nontransgenic B6 and line 151, 2761, and 140 single 
transgenic mice, and (right)  for 2C TCR + splenocytes from 
a 2C + single transgenic mouse and 151+2C +, 2761+2C +, 
and 140+2C + double transgenic mice. Splenocytes from the 
three CD8 transgenic lines show an increased level of CD8 
expression  relative to that seen in control nontransgenic B6 
littermates: 2.3 times (n  =  1) for 151, three times (n  =  4) 
for 2761, and six times (n  =  11) for 140. In the 2C TCR + 
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Figure 8.  High cell surface levels of CD8 trigger deletion of 2C TCR + 
tbymocytes. The CD8 fluorescence intensities of tbymocytes from non- 
transgenic C57BL/6J (B6), line 151, 2761, 140, and 2C TCR single trans- 
genics, and 151 +  2C +, 2761 +  2C +, and 140 +  2C + double transgenics are 
shown. Thymocytes were stained with FITC-conjugated  anti-CD8, PE- 
conjugated anti-CD4, and biotinylated anti-2C (1B2), followed by staining 
with streptavidin red 613. The histograms depict all cells analyzed (left) 
or all cells positive for the 2C TCR (right).  Markers are shown as in Fig. 
7. The mean CD8 fluorescences of the CD8 + thymocytes are 32 (B6), 
74 (151), 86 (2761), 295 (140), 474 (CD8  hi, 140), 29 (2C), 70 (151, 2C), 
95 (2761, 2C),  37 (140, 2C),  and 150 (CD8hi; 140, 2C). 
lymphocytes  from  the  151+2C §  and  2761+2C +  double 
transgenics,  the relative level of CD8 fluorescence does not 
change significantly from that  observed in the CD8 single 
transgenics, three times (n  =  5) and four times (n =  2), respec- 
tively.  In  the  140+2C +  double  transgenics,  however,  the 
mean CD8 fluorescence decreases fivefold from that measured 
in line 140 single transgenic  mice:  28 (n  =  10;  140 +  2C +) 
vs.  143 (n  =  11;  140 +  ) in Fig.  7. 
The 2C + single transgenic  shows two peaks of fluores- 
cence  on  splenocytes,  CD8-  and  CD8 n~  denoted  by 
markers  1  and  3,  respectively,  in  Fig.  7.  The  140+2C + 
double transgenic contains three peaks of fluorescence in the 
splenocyte population.  The first peak represents the CD8- 
cells,  whereas  the  second peak represents  CD8  n~  cells, 
which express levels of CD8 that are similar to those detected 
on  2C +  cells  in  the  140-2C +  single  transgenic,  a  mean 
fluorescence of 19 vs. 21. The third peak includes ceils staining 
with a CD8 fluorescence >70 and is designated by marker 
4. The number of cells staining with a CD8 fluorescence >70 
in the 140 + 2C + double transgenic drops dramatically com- 
pared with that in the 140 + single transgenics.  In line 140, 
32% of splenocytes fall within marker 4 (54% of the CD8 + 
cells) and these stain with a mean CD8 fluorescence of 248. 
In contrast,  in  140+2C + double transgenic  mice, <5%  of 
the  2C  TCR + cells  fall  within  marker  4,  and  these cells 
stain with a mean CD8 fluorescence of 122.  In the subse- 
quent discussions of these data, we will refer to T  cells ex- 
pressing CD8 at levels >200 as the CD8  hi cells; we will refer 
to the 2C TCR + T  cells  expressing CD8 at levels  >70 as 
the  CD8 m~  cells. 
The data in Figs.  6 and 7 clearly demonstrate  a specific 
loss of CD4-CD8 hi splenic T  ceUs relative  to CD4-CD8 m~ 
and CD4-CDP ~  splenic T cells in the 140+2C + double 
transgenic.  These resuhs raise the question of whether this 
absence of CD8  hi cells  results from thymocyte deletion or 
the absence of positive selection. 
CD8 hl Cells Are Deleted  in  the  Thymus  of the  140+2C + 
Double  Transgenic.  To  determine  if  2C+CD8 hi  cells  are 
deleted in the thymus of the double transgenic,  thymocytes 
from single and double transgenics were stained with anti- 
CD8,  anti-CD4,  and 1B2 antibodies.  The relative levels of 
CD8  fluorescence  among  the  three  classes  of transgenic 
progeny are plotted in Fig. 8. For comparison, progeny from 
the 151  x  2C and 2761  x  2C crosses were also included 
in this analysis. Thymocytes from 151 and 2761 single trans- 
genic mice stain with a mean CD8 fluorescence that is, respec- 
tively, 2.3- and 2.7-fold elevated above that measured on control 
B6 thymocytes (74 for 151 and 86 for 2761, compared with 
32 for B6). Similar to the analysis  of splenocytes in Fig. 7, 
no  significant  change was observed in the CD8 profile of 
thymocytes from the 151 § 2C + and 2761 +  2C + double trans- 
genics compared with that of the single transgenics. Thymo- 
cytes from the 151 +  2C + and 2761 +  2C + double transgenics 
stained with a relative mean CD8 fluorescence of two and 
three times (70 and 95, respectively). Thymocytes from the 
140+2C +  double  transgenics,  however,  exhibit  very  few 
CD8  hi ceils compared with line 140 single transgenics.  98% 
of thymocytes stain with a mean CD8 fluorescence of 295 
in line 140 single transgenics.  In contrast, only 54% of 2C + 
thymocytes express CD8 and they do so with a mean fluores- 
cence of 37,  an eightfold reduced level rdative to the line 
140 single transgenics.  Furthermore, whereas 74% of thymo- 
cytes in line 140 single transgenics stain at levels of fluores- 
cence that  are >70 in Fig. 8, only 6%  of 2C + thymocytes 
in the  140+2C + double transgenics  stain  at  or above this 
level.  Consequently,  these data show that  2C+CD8 hi ceils, 
as well as most 2C +  CD8  m~  ceils, are deleted in the thymus 
of  140+2C +  double  transgenics.  The  absence  of thymic 
CD8 hi cells is also shown by the decrease in the number of 
cells  staining for the CD8oe.1 transgene.  In the thymus of 
line  140  mice,  *80%  of thymocytes  stain  as  CD8ci.I+; 
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thymocytes stain  as  CD8ot.1 +  (data  not  shown;  these 
numbers represent averages from two to five mice). In con- 
trast, no decrease in the percent of CDSot.1 + thymocytes is 
observed in the 151 +  2C + and 2761 +  2C + double transgenics 
compared with the 151 + and 2761 + single transgenics (data 
not shown). 
Discussion 
To investigate the effect of increased levels of CD8ot sur- 
face expression on the developmental fate of maturing thymo- 
cytes, we generated a T cell-specific  expression cassette capable 
of promoting high level expression of heterologous genes in 
all T cell subsets in transgenic mice. This expression cassette, 
pNeZ, contains the promoter and enhancer elements of the 
murine CD3-~ gene, which is normally expressed  on all TCR- 
c~/3 and -~/6-bearing thymocytes  and peripheral T cells, and 
which is transcriptionally active in the thymus by embryonic 
day 15-16 (49). Transient expression experiments performed 
with cultured cells have demonstrated that while the CD3-6 
promoter is not cell type specific, the CD3-~ enhancer func- 
tions  preferentially in T  cells (33). 
As discussed in this paper, one transgenic line generated 
with the pNe2~DSc~.l construct, line 140, expressed  the CD8 
transgene on 75% of T cells at levels that are elevated 6-10- 
fold relative to endogenous CDSot gene expression. An ad- 
ditional seven  lines have  been produced that carry either human 
CD4 or murine and human CD8 transgenes inserted into 
the pNeZ cassette; all of these lines, including line 151 dis- 
cussed in this paper, express the heterologous transgenes on 
virtually 100% of thymocytes and mature T cells (N. Lee, 
D. Grass, D. Smith, and E. Lacy, unpublished results). Fur- 
thermore, the surface levels of expression of the CD4 and 
CD8 transgenes are equivalent on immature and mature T 
cells, indicating that the activity of the CD3-~ regulatory 
sequences is not modulated during thymocyte maturation. 
Previous experiments have suggested that the density of 
CD8 molecules on the surface of maturing thymocytes plays 
a crucial role in tolerance induction. For example, analysis 
of transgenic mice expressing a TCR spedfic for the HY male 
antigen has shown that T cells expressing this receptor, as 
well as low levels of CD8, can escape clonal deletion in males 
(50). Similarly, Sha et al. (27) observed deletion of CD8  hi, 
but not of CD8  I~ T cells in transgenic mice expressing the 
2C TCIL on a K  bin11 or K bin3 mutant background. Trans- 
genie lines expressing elevated  but very  distinct levels  of CD8ol 
(2-4 vs. 6-10 times) allowed us to test directly whether sur- 
face levels of CD8 can modulate the selection of the mature 
TCR repertoire.  We found no effect on thymocyte matura- 
tion in the double transgenic progeny from crosses between 
a line expressing the class I-restricted 2C TCR and lines 151 
and 2761, which express two- to fourfold increased levels of 
CDS. However, markedly different results were obtained in 
double transgenic progeny produced in the cross between the 
2C mice and line 140 mice, which express 6-10-fold elevated 
levels of CDS.  The numbers of peripheral T  cells that are 
CD8  hi, and thus that are CD8ot.1  transgene  positive,  are 
dramatically  reduced in the 140+2C + double transgenics. 
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The percentage of 2C TCR-expressing splenic T cells, how- 
ever,  is  comparable  between the  140+2C +  double trans- 
genies and the 2C § single transgenics. Although peripheral 
2C TCR + T  cells that express elevated levels of CD8 are 
found in the double transgenics, their numbers are few and 
their surface density of CD8 is lower than the mean density 
of CD8 on splenic T cells in line 140. In addition,  none of 
the 2C TCR + splenic T cells in the double transgenics ex- 
press the highest levels of CD8 observed in the line 140 mice 
(Figs. 6 and 7). As no CDShi2C + cells are detected in the 
thymus of the 140+2C + double transgenic, these cells must 
be deleted during thymocyte  maturation. The loss of the pe- 
ripheral double-positive cells in the double transgenic could 
reflect either deletion of most CD4+CD8  hi thymocytes ex- 
pressing the 2C TCR and/or an instructional mechanism for 
thymocyte maturation (51, 52). 
The overexpression of the CD8ot transgene does not per- 
turb endogenous CDSol or CD83 gene expression, and the 
excess CD8c~ molecules are likely to be expressed in the form 
of  c~/c~ homodimers rather than or/3 heterodimers. Since the 
CD8/3 chain cannot bind kk (53), it is formally  possible that 
the deletion of the 2C+CD8  ~ cells in the 140+2C + double 
transgenics results from a perturbation in signaling due to 
limiting quantities of kk or an increase in the amount of kk 
bound per CD8 dimer. We think such a general, nonspecific 
mechanism for the deletion of the 2C +  CD8  hi cells is un- 
likely, as the overexpression of the CD8c~ transgene in line 
140 mice is without apparent global effect on thymocyte matu- 
ration. Normal staining patterns are obtained with antibodies 
to other T cell surface markers, for example CD3 and TCR- 
or/B, in line 140 mice as well as in line 151 and 2761 mice 
(Fig. 5). In addition, the CD8 transgene-positive cells in line 
140 show normal proliferative responses in mixed lympho- 
cyte reactions to class I and class II alloantigens (N. A. Lee 
and E. Lacy, unpublished results).  The line  140 mice have 
also been crossed with the transgenic  line expressing the 
H-Y-specific TCR (54, 55) on the H-2  b positively selecting 
background. Interestingly,  in the double transgenic female 
progeny the CD8 hi, H-Y TCR-expressing thymocytes are 
not  deleted,  but  positively  selected (N.  A.  Lee, H.  yon 
Boehmer, and E. Lacy, unpublished results). This finding in- 
dicates that the effect of high levels of CD8 on thymocyte 
maturation is determined directly by the specificity of the 
TCR-cr  Thus, if the high levels of CD8 in line 140 mice 
are, in fact, globally altering signaling in maturing thymo- 
cytes, then the cellular response to these altered signals must 
be dictated by the specificity of TCRAelf-Ag-MHC inter- 
actions. 
Another interpretation of our data, and the one we favor, 
is that the deletion of the 2C+CD8  hi cells reflects the out- 
come of a synergistic collaboration between the excess  levels 
of CD8 and the 2C TCR, and that this collaboration  acts 
to increase the avidity of the interaction between immature 
thymocytes  and selecting MHC class I-positive stromal cells. 
T  cell maturation requires positive and negative selection, 
both of which are mediated by interactions between a TCR 
on a maturing thymocyte  and a MHC/self-peptide ligand on 
a selecting cell in the thymus (27-30;  54). Thus, to avoid deleting or inactivating the positively selected TCK reper- 
toire, either the thymocyte itself or the selecting stromal cell 
must be able to distinguish between positively and negatively 
selecting interactions between the TCK and MHC.  The 
affinity model (29, 56) proposes that the choice between posi- 
tive and negative selection is based on the affinity of the in- 
teraction between a TCK and a MHC/self-peptide ligand. 
Thymocytes  expressing  TCRs  with  high  affinity  for 
MHC/self-peptide ligands would be eliminated by the mech- 
anisms for tolerance induction, whereas thymocytes  expressing 
receptors with low or moderate affinities would be allowed 
to mature. A refinement of this model is that the levels of 
binding by CD8 and CD4 to class I and class II molecules, 
respectively, can contribute either to the affinity of the TCK 
complex for its selecting MHC molecule or to the overall 
avidity of a thymocyte for a selecting stromal cell. 
In the 2C  x  140 cross, as well as in the 2C  x  151 and 
2761 crosses, we have not altered the expression of the 2C 
TCR transgene nor of endogenous MHCAelf-peptide com- 
plexes; thus, we believe our data demonstrate directly that 
CD8 levels can affect the developmental fate of a maturing 
thymocyte. Our data also argue in support of an affinity model 
for thymocyte selection in which the affinity  of a TCR: 
MHCAelf-peptide interaction is translated into a graded signal 
that is measured by the maturing thymocyte. A signal above 
a certain threshold would result in donal deletion, whereas 
a signal below a certain level would result in positive selec- 
tion; a signal in an intermediate range, on the other hand, 
might trigger donal anergy. A distinct advantage of the 2C 
TCR transgenic system  is  that this interpretation of our 
findings can be confirmed and extended by crossing the 2C 
TCR  and line  140  CD8  hi transgenes onto different H-2 
backgrounds. Sha et al. (27, 48) have shown that the selec- 
tion of the 2C TCR varies dramatically on different H-2 back- 
grounds. On the H-2', H-2  k, and H-2 K bins backgrounds, 
the 2C TCR is weakly positively selected, whereas it is weakly 
negatively selected on the H-2 K bin3 and K  bin11 backgrounds. 
If the affinity model is an accurate interpretation of the selec- 
tion process, then these observations most likely reflect the 
different affinities of the 2C TCK for the different selecting 
MHC class IAelf-peptide ligands.  Furthermore, the affinity 
model argues that the line 140 CD8  hi transgene should affect 
the selection of the 2C TCR in predictable ways on these 
different H-2 backgrounds. For example,  K b~s should be- 
come a strongly positively selecting background and K bm3 
and K  bin11 should become strongly negatively selecting back- 
grounds. Another question that can be addressed using this 
transgenic system is whether the 2C+CD8 m~  T cells in the 
151 +  2C + and 2761  +  2C + double transgenics are function- 
ally competent against the L a antigen or whether they are 
anergic.  The finding that the 2C TCR+CD8  ~~  cells are 
anergic would support the proposal that the choice to clonaUy 
anergize  a thymocyte is also determined by the affinity of 
a TCR:MHCAelf-peptide interaction. 
Although our experimental results support an affinity model 
for thymocyte selection, they do not address the mechanism 
by which CD8 could be contributing to the avidity of thymo- 
cyteAtromal cell interactions. Studies on CD8 function during 
alloreactive cytolytic responses indicate that CD8 participates 
in T cell activation largely as a coreceptor that engages the 
same MHC molecule as the TCK (9, 10). Numerous other 
studies (57-61)  have demonstrated that CD8 can also con- 
tribute to T  cell recognition and activation as an adhesion 
molecule that binds bystander MHC class I molecules not 
involved in antigen presentation to the responding TCK. Anal- 
ysis of CD8-deficient mice has shown that CD8 is essential 
for the selection  of dass I-restricted TCK (62).  It is not 
known, however, whether CD8 participates  in thymocyte 
selection as a coreceptor and/or as an adhesion molecule. Thus, 
the elevated levels of CDSot could be affecting  the avidity 
of the 2C TCR + thymocytes via one or both of these mech- 
anisms. 
If the excess levels of CDSo~ enhance the avidity of thymo- 
cyteAtromal cell interactions through a coreceptor mecha- 
nism, then the number of 2C TCRs that can coengage an 
MHCAelf-peptide ligand with CD8 must be increased in the 
2C TCK/140 double transgenics. This would imply that the 
elevated surface levels of CD8 may effectively increase the fie- 
quency with which both CD8 and the TCR simultaneously 
contact MHCAelf-peptide. Alternatively,  the increased ex- 
pression of CD8 in line 140 may result in elevated levels of 
a particular form ofCD8 (ol/o~, ex' etc.) that alters the affinity 
of the TCR:MHC/self-peptide interaction. Another possi- 
bility is that the elevated levels of CD8c~ might increase the 
overall  avidity  of thymocyteAtromal cell  interactions by 
binding class I molecules not engaged by the 2C TCK. Con- 
sistent with such a mechanism are the data from O'Rourke 
et al.  (58) showing that CD8 binding to bystander dass I 
molecules is increased by TCR engagement by an anti-TCR 
antibody. Through either a coreceptor or adhesion function, 
the increased levels of CDSo~ may enhance signals generated 
during  thymocyte selection,  such  that  they  surpass  the 
threshold required to trigger negative selection. 
Another model to resolve the paradox of thymocyte selec- 
tion is the altered ligand model. This model proposes that 
a distinct set of self-peptides, presented exclusively by the cor- 
tical epithelium, mediates positive selection, whereas another 
set of peptides, expressed both by thymic stromal cells and 
nonthymic tissues, mediates negative selection (21, 63). Our 
experiments do not address this model, because we do not 
know whether the same K b self-peptide  ligand that posi- 
tively selects the 2C TCR in the single transgenic also nega- 
tively selects the 2C TCR in the double transgenic.  For ex- 
ample, in the double transgenic, the 2C TCR may be positively 
selected by the same cortical K  b self-peptide ligand as in the 
single transgenic, but deleted by another MHC/self-peptide 
due to an enhanced affinity. However,  even if distinct sets 
of self-peptides  and antigen-presenting cells are used for positive 
and negative selection, our results would argue that affinity 
is still a component of the selection process. The availability 
of transgenic mice expressing different levels of CD8 will allow 
us to explore different facets of the role of affinity in thymo- 
cyte maturation. 
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